3646 results for «821»
3646 results
TAVI outcomes
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...
Coronary physiology: FFR and beyond
22 May 2025 – From EuroPCR 2025
Advance your understanding of coronary physiology with a focus on fractional flow reserve (FFR) and beyond. This session covers randomized trials comparing physiology-guided treatment to standard care in ANOCA, graft patency related to quantitative flow ratio, impacts of microvascular dysfunction on patient outcomes, and prognostic value...
All you need to know on aorto iliac disease during TAVI: from access to complications management
22 May 2025 – From EuroPCR 2025
Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.
Challenging session in calcified lesions
22 May 2025 – From EuroPCR 2025
Engage with a challenging session focused on complex calcified lesion interventions. Topics include innovative triple burr techniques, OCT insights into resistant lesions, volume reduction strategies, eccentric calcium management, and IVUS-guided left main calcified lesion treatment, highlighting practical approaches to difficult cases.
TAVI in bicuspid aortic valve disease
22 May 2025 – From EuroPCR 2025
Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.
Leaflet modification to prevent coronary obstruction during TAVI
22 May 2025 – From EuroPCR 2025
This session addresses advanced leaflet modification techniques to prevent coronary obstruction during TAVI. Learn from detailed cases involving valve-in-valve interventions, treatment of failed stentless valves, homograft management, and dedicated devices for leaflet modification prior to valve-in-valve and valve-in-valve-in-valve procedures.
Advanced tools for the diagnosis of coronary artery disease
22 May 2025 – From EuroPCR 2025
This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.
Shock and PCI: due to ECMO I survived
22 May 2025 – From EuroPCR 2025
Explore life-saving strategies in the management of cardiogenic shock complicating PCI, with emphasis on ECMO utilization. This session reviews challenging cardiac arrest cases, multi-culprit STEMI scenarios, and innovative STEMI treatments in critical patients, illustrating how ECMO support can be pivotal in survival and recovery.
Redefining the red flags: early detection of myocardial infarction in women
22 May 2025 – From EuroPCR 2025
Gain a unique patient-centered perspective on early myocardial infarction detection in women. This session features a survivor's story, collaborative step-by-step clinical approaches, and key aspects of cardiac rehabilitation, emphasizing shared decision-making to improve patient outcomes in complex cases.
Management of complex left main trifurcation lesion
22 May 2025 – From EuroPCR 2025
This session focuses on the management of complex left main trifurcation lesions. Review hybrid and double TAP techniques, long-term follow-up outcomes, and innovative approaches such as the inverted double TAP technique, offering insights into optimizing treatment strategies for these challenging anatomical scenarios.
TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation
22 May 2025 – From EuroPCR 2025
Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
Redo TAVI - How to treat different TAVI platforms when they fail
22 May 2025 – From EuroPCR 2025
Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.
High thrombus burden in STEMI
22 May 2025 – From EuroPCR 2025
This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.
TAVI in women
22 May 2025 – From EuroPCR 2025
Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...
Artificial intelligence in the cathlab
22 May 2025 – From EuroPCR 2025
Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
Integrating CT coronary angiography into your PCI practice
22 May 2025 – From EuroPCR 2025
Integrate CT coronary angiography into your PCI practice to enhance procedural planning and outcomes. This session covers practical CT-based approaches for guiding catheter selection, lesion analysis, and stenting strategy. Learn how to leverage CT imaging to anticipate plaque preparation needs in calcified lesions and optimize catheterization...
Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use
22 May 2025 – From EuroPCR 2025
Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.
Procedural aspects of DCB PCI
22 May 2025 – From EuroPCR 2025
Delve into procedural aspects of drug-coated balloon (DCB) PCI with a focus on lesion preparation, antiplatelet therapy, and outcomes in real-world settings. This session reviews the impact of pre-dilatation balloons on de novo lesions, compares ticagrelor versus clopidogrel post-PCI with drug-eluting balloons, and discusses streamlined revascularization...
